A Study Evaluating the Efficacy, Safety, and Tolerability of Ertapenem versus Ceftriaxone for the Treatment of Community‐Acquired Pneumonia in Adults

Authors:
  • PGProtocol 018 Ertapenem Community-Acquired Pneumonia Study Group
    Protocol 018 Ertapenem Community-Acquired Pneumonia Study Group

Abstract
In a double-blind, multicenter trial, 502 patients hospitalized with community-acquired pneumonia were randomized to receive therapy with either erta

This publication has 18 references indexed in Scilit: